Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023
Sat, April 1, 2023
Fri, March 31, 2023
Thu, March 30, 2023

Matthew Harrison Maintained (BLUE) at Sell with Decreased Target to $3 on, Apr 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-3-on-apr-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Sell with Decreased Target from $4 to $3 on, Apr 3rd, 2023.

Matthew has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Maintained at Hold with Decreased Target to $6 on, Thursday, March 30th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $8 on, Thursday, March 30th, 2023
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Monday, January 23rd, 2023


This is the rating of the analyst that currently disagrees with Matthew


  • Jack Allen of "Baird" Initiated at Buy and Held Target at $10 on, Tuesday, March 7th, 2023

Publication Contributing Sources